Chiasma completes enrolment in Phase lll trial of octreotide
Chiasma has completed patent enrolment in its Phase lll CHIASMA OPTIMAL clinical trial evaluating octreotide...
Chiasma has completed patent enrolment in its Phase lll CHIASMA OPTIMAL clinical trial evaluating octreotide...